The company said it expects to have doses ready for 80,000 patients ready by the end of November and approximately 300,000 patients in total by the end of January 2021.
These will be available to US patients at no out-of-pocket cost under the terms of a US government program.
End quote
Socialized medicine?
"When one’s appeal is emotional, it does not matter if there is no substance."
